Gilead Sciences, Inc. (Public, NASDAQ:GILD) Gilead Sciences Extends Expiration Date for Tender Offer for Myogen Until November 13, 2006 FOSTER CITY,...
Genzyme Corporation (Public, NASDAQ:GENZ) Genzyme sells new gene test for cystic fibrosis The biotechnology company said the diagnostic test can detect about ...
Invitrogen Corporation (Public, NASDAQ:IVGN) Stratagene Ordered to Shell Out Triple the Amount Previously Awarded in the Invitrogen Lawsuit In a patent...
Serono S.A. (ADR) (Public, NYSE:SRA) Germany's Merck gets US antitrust nod for Serono WASHINGTON, Oct 31 (Reuters) - U.S. antitrust authorities have approved...
Genentech, Inc. DNA Genentech Repeats as 'Fastest Company in Silicon Valley' in 2006 Comerica Corporate Challenge at Metro Silicon Valley Marathon SAN JOSE,...
Forest Laboratories, Inc. (Public, NYSE:FRX) Forest Laboratories recruitment to resume in stroke trial Forest Laboratories Inc. (FRX) plans to resume patient...
Amgen, Inc. (Public, NASDAQ:AMGN) Amgen, Inc. AMGN Amgen Foundation Launches $25 Million Amgen Scolars Program. Amgen Foundation Launches $25 Million...
Hospira, Inc. (Public, NYSE:HSP) George Soros sold out his holdings in Pharmaceuticals operator Hospira Inc.(HSP) during the 3-months ended 2006-06-30. His...
Cardinal Health, Inc. (Public, NYSE:CAH) DuPont reaches settlement with Cardinal Health Business First of Columbus - October 30, 2006 Print this Article Email...
Biogen Idec Inc. (Public, NASDAQ:BIIB) In earnings news, Biogen Idec (NASDAQ:BIIB) announced third-quarter net profit of $156.6 million, or 45 cents per...
Vertex Pharmaceuticals Incorporated (Public, NASDAQ:VRTX) Vertex presents mixed results in hepatitis C drug 30th October 2006 By Victoria Harrison Vertex has...
MedImmune, Inc. (Public, NASDAQ:MEDI) MedImmune to Present at the CIBC World Markets 17th Annual Healthcare Conference and ViroPharma to Present at the Cowen...
Celgene Corporation (Public, NASDAQ:CELG) Gilead Sciences Completes Acquisition of Raylo Chemicals Inc. and Celgene Announces Pricing of Common Stock Offering...
Allergan, Inc. (Public, NYSE:AGN) Allergan profit falls in 3Q, plans to buy French company Los Angeles Business from bizjournals - November 1, 2006 Print this...
Abraxis BioScience, Inc. (Public, NASDAQ:ABBI) Abraxis BioScience Launches New Abraxane Patient Assistance Program Comprehensive Program Provides Access to...
Myriad Genetics, Inc. (Public, NASDAQ:MYGN) Myriad Genetics Announces First Quarter Fiscal 2007 Financial Results Conference Call SALT LAKE CITY Myriad...
Bodisen Biotech, Inc. (Public, AMEX:BBC) Bodisen Biotech, Inc. to Report Third Quarter 2006 Financial Results On November 15, 2006 Bodisen Biotech, Inc....
ImClone Systems Incorporated (Public, NASDAQ:IMCL) Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer - NCIC CTG...
Sinovac Biotech Ltd. (Public, AMEX:SVA) Sinovac Biotech Ltd. Engages The Ruth Group as Investor Relations And Public Relations Counsel Sinovac Biotech Ltd....
Myogen, Inc. (Public, NASDAQ:MYOG) J. William Freytag, Ph.D., President & CEO of Myogen to Be Special Guest at 14th Annual Biotech Investing Conference NEW...
Human Genome Sciences (Public, NASDAQ:HGSI) Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2006 Financial Results Human Genome...
TGen to hold 2006 Pancreatic Cancer Research Symposium (Forum brings together national leaders in pancreatic cancer research and patients) 11-30-2006 Friday,...
Scan of Entire Human Genome Finds Unexpected New Clues on Lou Gehrig's Disease 11-30-2006 TUCSON, Ariz., Nov. 30, 2006 -- A comprehensive scan of the human...
Arizona biotech industry ahead of 10-year schedule By Joe Pangburn, Inside Tucson Business Posted: Friday, Dec 08, 2006 - 02:17:06 pm MST Bioscience is taking...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
